Gayle Marshall is Lead Scientist for Biomarkers at MDC. She has extensive experience in clinical and pre-clinical biomarkers, previously leading a translational science laboratory team within large pharma. At MDC, she is responsible for delivering biomarker strategies and developing robust assays for clinical utility through delivering key data to support clinical development.
Designing a biomarker strategy
Thinking about biomarkers early in your drug discovery project and defining a clear biomarker strategy to address a range of clinical questions
